You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 7 Next »

Harm reduction supply distribution

The following data elements will be collected and stored by core Needle Syringe Program workers, workers funded under the AIDS Bureau Harm Reduction Outreach program, and Hep C Team outreach workers when distributing harm reduction supplies.


Data elementPermissible values
Site information

Site Name

Any site name chosen by the participating agency is acceptable.

Affiliated PHU

One of the 35 public health units in Ontario.

Programs provided

One or more of:

  • Needle Exchange
  • Harm reduction outreach
  • Hep C Team
  • Ontario Naloxone Program

Client information

Anonymous Client Code (part of the client reference code)Exactly 4 letters
Year of birth (part of the client reference code)4-digit year, between 1901 and 2018
Gender (part of the client reference code)
  • Male
  • Female
  • Trans Male
  • Trans Female
  • Other gender not listed
Postal code of residence (Forward Sortation Area only)
  • The first three characters of any valid postal code within Ontario (e.g. M5A)
  • Do not know
  • No fixed address
  • Outside of Ontario


Substances used

This field can be left blank (non-mandatory field); the permissible options are below.

  • Alcohol

  • Amphetamines

  • Antidepressants

  • Benzodiazepines (Valium, Xanax, Ativan, etc.)

  • Cannabis (prescription/medical use)

  • Cannabis (recreational use)

  • Cocaine

  • Codeine

  • Crack / cocaine

  • Dilaudid/ Hydromorphone

  • Fentanyl (non-prescribed)

  • Fentanyl (prescribed)

  • Heroin

  • Hydrocodone

  • Inhalants (solvents such as gasoline, glue, aerosols such as spray paint,  gases)

  • Kadian

  • Ketamine

  • Methadone (non-prescribed)

  • Methadone (prescribed)

  • Methamphetamine (Crystal Meth)

  • Methamphetamine (speed)

  • Morphine

  • Non-beverage Alcohol (e.g., Listerine, other mouthwash, cooking wine, hand sanitizer, etc.)

  • Other

  • Oxycodone/Percocet/OxyNEO

  • Party Drugs (Ecstasy, MDMA, K, GHB, etc.)

  • Ritalin/methylphenidate

  • Speedball (crystal meth/fentanyl)

  • Speedball (crystal meth/hydromorphone/Dilaudid)

  • Speedball (fentanyl/crack)

  • Speedball/other polysubstance

  • Steroids/ testosterone

  • Suboxone/ buprenorphine (non-prescribed)

  • Suboxone/ buprenorphine (prescribed)

  • Unknown

  • Unspecified opioid

  • Unspecified stimulant
  • Wellbutrin/bupropion

NSP transaction information

Date of transaction

dd/mm/yyyy

Location of transaction
  • In-service NEP/NSP (core or satellite)
  • Addiction programs (e.g., residential and day programs)
  • Bars/night clubs
  • Residence (e.g., client home, apartment/house, hotel/motel, friend's place, place where client resides, etc.)
  • Community agencies/services (that are not fixed site needle exchange programs, e.g., church basement for the out of the cold program, shelters, etc.)
  • Community public spaces (e.g., barbershop, hair salon, bathhouse, massage parlour, etc.)
  • Jails/detention centres/prisons
  • Opioid agonist therapy clinics
  • Parties/raves
  • Pharmacies
  • Street/parks (e.g., you are on foot and distributing safer injection or inhalation equipment)
  • Mobile distribution from a van (e.g., driving a route and distributing from a van/car, does not include driving to a specific location to deliver supplies)
Client collecting on behalf of
  • Self
  • Self and others
  • Others only
Additional services provided
  • Brief Counselling
  • Harm Reduction Teaching
  • Indigenous Traditional Services
  • Practical Support
Referrals provided
  • Addictions services
  • Clinical service providers - HIV Care
  • Clinical service providers - Other Care
  • Clinical service providers - Primary Care
  • Clinical service providers - Urgent Care
  • Community event
  • Community-based HIV service providers
  • Harm reduction services
  • Hep C teams
  • Hep C testing other (non-Hep C team)
  • Hep C treatment other (non-Hep C team)
  • HIV/STI testing
  • Mental health service providers
  • Other community-based service providers
Safer injection equipment providedDetermined by the types of needles and supplies distributed at site.


Safer inhalation equipment provided
Other equipment provided
Safer sex supplies provided
Needles returned and Community Clean-up information

Date needles were returned

dd/mm/yyyy

Quantity of needles returned

Number

Date of community clean-up

dd/mm/yyyy

Ontario Naloxone Program

Organizations that report to the Ontario Naloxone Program need only to fulfill the requirements of the ONP Quarterly Report. NEO can be used to collect this data on a client-by-client basis (i.e. service providers record an encounter in NEO every time they distribute/train for the naloxone program), or this data can be submitted in bulk once a quarter.


Data elementPermissible values

Naloxone - distribution

Total number of naloxone kits distributed

  • Intra-nasal kit
  • Intra-muscular kit
Total number of trainings to administer naloxone provided
  • Intra-nasal training
  • Intra-muscular training
Total number of individuals who received naloxone refills
  • # of individuals who received 1 refill
  • # of individuals who received 2 refill
  • # of individuals who received 3 refill
  • # of individuals who received 4 refill
  • # of individuals who received 5 refill

(Differentiated by intra-nasal or intra-muscular dose, e.g. "1 intra-nasal dose")

(Optional) Reported reasons for resupply of naloxone kit
  • Kit broken/contents missing
  • Kit confiscated
  • Kit expired
  • Kit given away
  • Kit lost
  • Kit recalled
  • Kit used
(Optional) Reported access point for previous naloxone kit
  • This ONP site
  • Other ONP site
  • Pharmacy
  • Correctional facility
  • Another individual
Naloxone - administration





(Optional) Type of individual who reported administration of naloxone

  • Client
  • Friend or family member
  • Recently released inmate

(Optional) Location of overdose

  • At home/residence
  • On the street
  • Outside of local area

Number of doses individual reported they administered for the overdose

  • 1
  • 2
  • 3
  • 4
  • 5 or more

(Differentiated by intra-nasal or intra-muscular dose, e.g. "1 intra-nasal dose")

Individual reported calling 911 when naloxone administered

  • Yes
  • No

(Optional) Individual reported someone stayed with person until paramedics arrived or person recovered

  • Yes
  • No

(Optional) Drugs used when overdose occurred

Same as list provided under Substances Used

(Optional) Reported outcome of naloxone administration

  • Resuscitation successful
  • Resuscitation unsuccessful
  • Unknown






  • No labels